FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307703039> ?p ?o ?g. }

• W4307703039 endingPage "467" @default.
• W4307703039 startingPage "461" @default.
• W4307703039 abstract "Current evidence on benefits of night-time blood pressure (BP) lowering drug treatment on cardiovascular disease (CVD) prevention attributable to the Ambulatory Blood Pressure Monitoring in the Prediction of Cardiovascular Events and Effects of Chronotherapy (MAPEC) trial and Bedtime hypertension treatment improves cardiovascular risk reduction (Hygia) trials has raised concern on their validity and methodology. In this commentary, the authors have updated the progress of the ongoing trials that were planned to examine the effect of night-time BP lowering drug treatment on CVD prevention. As compared to MAPEC and Hygia trials, three pragmatic trials the Blood Pressure Medication Timing (BPMedtime) trial (US), the Treatment In Morning versus Evening (TIME) trial (UK), Bedmed and Bedmed-frail (Canada) were planned without ambulatory BP monitoring. The BPMedtime trial was stopped after the pilot phase due to underestimated sample size and insufficient funds. TIME trial (UK) had a similar issue when changing the sample size from 10,269 to more than 20,000 participants. The TIME trial was completed and the initial results showing that protection against heart attack, stroke and vascular death is not affected by whether antihypertensive medications are taken in the morning or evening. The full study of the TIME trial is published in December 2022. Bedmed and Bedmed-frail trials are ongoing and will be completed in 2023. Time of taking BP lowering drug should be determined by patients at their convenience to improve the adherence. There was no difference in adverse effects of taking BP lowering drugs at night or morning. Evidence on the effect of night-time treatment on CVD events is inconsistent. The results from ongoing trials in Canada will contribute evidence to the use of BP lowering drug treatment for the prevention of CVD." @default.
• W4307703039 created "2022-11-05" @default.
• W4307703039 creator A5027721999 @default.
• W4307703039 creator A5041942546 @default.
• W4307703039 date "2022-10-27" @default.
• W4307703039 modified "2023-10-01" @default.
• W4307703039 title "Update on trials examining effects of night-time blood pressure lowering drug treatment on prevention of cardiovascular disease" @default.
• W4307703039 cites W180946569 @default.
• W4307703039 cites W1980533403 @default.
• W4307703039 cites W2028817265 @default.
• W4307703039 cites W2046650731 @default.
• W4307703039 cites W2084955832 @default.
• W4307703039 cites W2089165533 @default.
• W4307703039 cites W2116239162 @default.
• W4307703039 cites W2117007117 @default.
• W4307703039 cites W2131365674 @default.
• W4307703039 cites W2154023819 @default.
• W4307703039 cites W2167915551 @default.
• W4307703039 cites W2256980343 @default.
• W4307703039 cites W2275906638 @default.
• W4307703039 cites W2403172859 @default.
• W4307703039 cites W2571939482 @default.
• W4307703039 cites W2604204716 @default.
• W4307703039 cites W2754542146 @default.
• W4307703039 cites W2799514386 @default.
• W4307703039 cites W2894724600 @default.
• W4307703039 cites W2911645144 @default.
• W4307703039 cites W2982141734 @default.
• W4307703039 cites W3020781685 @default.
• W4307703039 cites W3023529892 @default.
• W4307703039 cites W3027744497 @default.
• W4307703039 cites W3096735544 @default.
• W4307703039 cites W3115121314 @default.
• W4307703039 cites W3123160913 @default.
• W4307703039 cites W3135466945 @default.
• W4307703039 cites W3161208735 @default.
• W4307703039 cites W3181507424 @default.
• W4307703039 cites W3189195688 @default.
• W4307703039 cites W3196414337 @default.
• W4307703039 cites W4213412556 @default.
• W4307703039 cites W4243746873 @default.
• W4307703039 doi "https://doi.org/10.37349/emed.2022.00107" @default.
• W4307703039 hasPublicationYear "2022" @default.
• W4307703039 type Work @default.
• W4307703039 citedByCount "1" @default.
• W4307703039 countsByYear W43077030392023 @default.
• W4307703039 crossrefType "journal-article" @default.
• W4307703039 hasAuthorship W4307703039A5027721999 @default.
• W4307703039 hasAuthorship W4307703039A5041942546 @default.
• W4307703039 hasBestOaLocation W43077030391 @default.
• W4307703039 hasConcept C121332964 @default.
• W4307703039 hasConcept C126322002 @default.
• W4307703039 hasConcept C127413603 @default.
• W4307703039 hasConcept C1276947 @default.
• W4307703039 hasConcept C149323552 @default.
• W4307703039 hasConcept C168563851 @default.
• W4307703039 hasConcept C177713679 @default.
• W4307703039 hasConcept C19720800 @default.
• W4307703039 hasConcept C197934379 @default.
• W4307703039 hasConcept C2776476923 @default.
• W4307703039 hasConcept C2778537899 @default.
• W4307703039 hasConcept C2779910239 @default.
• W4307703039 hasConcept C2780192228 @default.
• W4307703039 hasConcept C2780645631 @default.
• W4307703039 hasConcept C535046627 @default.
• W4307703039 hasConcept C71924100 @default.
• W4307703039 hasConcept C78519656 @default.
• W4307703039 hasConcept C84393581 @default.
• W4307703039 hasConceptScore W4307703039C121332964 @default.
• W4307703039 hasConceptScore W4307703039C126322002 @default.
• W4307703039 hasConceptScore W4307703039C127413603 @default.
• W4307703039 hasConceptScore W4307703039C1276947 @default.
• W4307703039 hasConceptScore W4307703039C149323552 @default.
• W4307703039 hasConceptScore W4307703039C168563851 @default.
• W4307703039 hasConceptScore W4307703039C177713679 @default.
• W4307703039 hasConceptScore W4307703039C19720800 @default.
• W4307703039 hasConceptScore W4307703039C197934379 @default.
• W4307703039 hasConceptScore W4307703039C2776476923 @default.
• W4307703039 hasConceptScore W4307703039C2778537899 @default.
• W4307703039 hasConceptScore W4307703039C2779910239 @default.
• W4307703039 hasConceptScore W4307703039C2780192228 @default.
• W4307703039 hasConceptScore W4307703039C2780645631 @default.
• W4307703039 hasConceptScore W4307703039C535046627 @default.
• W4307703039 hasConceptScore W4307703039C71924100 @default.
• W4307703039 hasConceptScore W4307703039C78519656 @default.
• W4307703039 hasConceptScore W4307703039C84393581 @default.
• W4307703039 hasFunder F4320334705 @default.
• W4307703039 hasIssue "3" @default.
• W4307703039 hasLocation W43077030391 @default.
• W4307703039 hasOpenAccess W4307703039 @default.
• W4307703039 hasPrimaryLocation W43077030391 @default.
• W4307703039 hasRelatedWork W2074509273 @default.
• W4307703039 hasRelatedWork W2088421142 @default.
• W4307703039 hasRelatedWork W2090850981 @default.
• W4307703039 hasRelatedWork W2118650061 @default.
• W4307703039 hasRelatedWork W2161397615 @default.
• W4307703039 hasRelatedWork W2307440621 @default.
• W4307703039 hasRelatedWork W2355904930 @default.

• next